BioCentury
ARTICLE | Clinical News

Ciba Corning Diagnostics Corp. regulatory update

September 26, 1994 7:00 AM UTC

Ciba Corning received FDA approval to market the ACS PSA immunoassay, a direct chemiluminescent blood test that determines the level of prostate specific antigen (PSA). The Norwood, Mass., company sai...